LXR is a negative regulator of glucose uptake in human adipocytes

Diabetologia

Volumn 56, Issue 9, 2013, Pages 2044-2054

  Pettersson, A M L ^a   Stenson, B M ^a   Lorente Cebrian S ^a   Andersson, D P ^a   Mejhert, N ^a   Kratzel J ^a   Astrom G ^a   Dahlman, I ^a   Chibalin, A V ^a   Arner, P ^a   Laurencikiene, J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Glucose uptake; Human adipocytes; Insulin signalling; Lipogenesis; Liver X receptor

Indexed keywords

GLUCOSE TRANSPORTER 4; LIVER X RECEPTOR; MESSENGER RNA; MICRORNA; PROTEIN KINASE B BETA; TRANSCRIPTOME;

ADIPOCYTE; AKT2 GENE; ARTICLE; CAP GENE; CAV1 GENE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSULIN RESPONSE; LIPOGENESIS; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SORBS1 GENE; WESTERN BLOTTING;

ADIPOCYTES; BENZOATES; BENZYLAMINES; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; HUMANS; ORPHAN NUCLEAR RECEPTORS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84881613874     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2954-5     Document Type: Article

References (50)

1. Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367-377
2. Leto D, Saltiel AR (2012) Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 13:383-396
3. Chiang SH, Baumann CA, Kanzaki M et al (2001) Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410:944-948
4. Miura A, Sajan MP, Standaert ML et al (2003) Cbl PYXXM motifs activate the P85 subunit of phosphatidylinositol 3-kinase, Crk, atypical protein kinase C, and glucose transport during thiazolidinedione action in 3T3/L1 and human adipocytes. Biochemistry 42:14335-14341
5. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers MG Jr, Ishikawa Y (1998) Caveolin is an activator of insulin receptor signaling. J Biol Chem 273:26962-26968
6. Olson AL, Pessin JE (1996) Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr 16:235-256
7. Trajkovski M, Hausser J, Soutschek J et al (2011) MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474:649-653
8. Baranowski M (2008) Biological role of liver X receptors. J Physiol Pharmacol 59(Suppl 7):31-55
9. Dahlman I, Nilsson M, Jiao H et al (2006) Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity. Pharmacogenet Genomics 16:881-889
10. Dahlman I, Nilsson M, Gu HF et al (2009) Functional and genetic analysis in type 2 diabetes of liver X receptor alleles - a cohort study. BMC Med Genet 10:27
11. Solaas K, Legry V, Retterstol K et al (2010) Suggestive evidence of associations between liver X receptor beta polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe). BMC Med Genet 11:144
12. Ross SE, Erickson RL, Gerin I et al (2002) Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Mol Cell Biol 22:5989-5999
13. Laffitte BA, Chao LC, Li J et al (2003) Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A 100:5419-5424
14. Dalen KT, Ulven SM, Bamberg K, Gustafsson JA, Nebb HI (2003) Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha. J Biol Chem 278:48283-48291
15. Griesel BA, Weems J, Russell RA, Abel ED, Humphries K, Olson AL (2010) Acute inhibition of fatty acid import inhibits GLUT4 transcription in adipose tissue, but not skeletal or cardiac muscle tissue, partly through liver X receptor (LXR) signaling. Diabetes 59:800-807
16. Commerford SR, Vargas L, Dorfman SE et al (2007) Dissection of the insulin-sensitizing effect of liver X receptor ligands. Mol Endocrinol 21:3002-3012
17. Fernandez-Veledo S, Vila-Bedmar R, Nieto-Vazquez I, Lorenzo M (2009) c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists. J Clin Endocrinol Metab 94:3583-3593
18. Fernandez-Veledo S, Nieto-Vazquez I, de Castro J et al (2008) Hyperinsulinemia induces insulin resistance on glucose and lipid metabolism in a human adipocytic cell line: paracrine interaction with myocytes. J Clin Endocrinol Metab 93:2866-2876
19. Hessvik NP, Bakke SS, Smith R et al (2012) The liver X receptor modulator 22(S)-hydroxycholesterol exerts cell-type specific effects on lipid and glucose metabolism. J Steroid Biochem Mol Biol 128:154-164
20. Arner E, Mejhert N, Kulyte A et al (2012) Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes 61:1986-1993
21. van Harmelen V, Skurk T, Hauner H (2005) Primary culture and differentiation of human adipocyte precursor cells. Methods Mol Med 107:125-135
22. Dicker A, Le Blanc K, Astrom G et al (2005) Functional studies of mesenchymal stem cells derived from adult human adipose tissue. Exp Cell Res 308:283-290
23. Rodriguez AM, Pisani D, Dechesne CA et al (2005) Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 201:1397-1405
24. Zaragosi LE, Ailhaud G, Dani C (2006) Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 24:2412-2419
25. Rodbell M (1964) Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380
26. Collins JL, Fivush AM, Watson MA et al (2002) Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 45:1963-1966
27. Stenson BM, Ryden M, Steffensen KR et al (2009) Activation of liver X receptor regulates substrate oxidation in white adipocytes. Endocrinology 150:4104-4113
28. Gerin I, Dolinsky VW, Shackman JG et al (2005) LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem 280:23024-23031
29. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408
30. Lofgren P, van Harmelen V, Reynisdottir S et al (2000) Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes 49:688-692
31. Arner P, Engfeldt P (1987) Fasting-mediated alteration studies in insulin action on lipolysis and lipogenesis in obese women. Am J Physiol 253:E193-E201
32. Elmensdorf JS (2003) Fractionation analysis of the subcellular distribution of GLUT-4 in 3T3-L1 adipocytes. In: Özcan S (ed) Diabetes mellitus: methods and protocols. Humana Press, Totowa, pp 105-111
33. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33:W741-W748
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
35. Grefhorst A, van Dijk TH, Hammer A et al (2005) Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab 289:E829-E838
36. Kotokorpi P, Ellis E, Parini P et al (2007) Physiological differences between human and rat primary hepatocytes in response to liver X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl) amino]propyloxy]phe nylacetic acid hydrochloride (GW3965). Mol Pharmacol 72:947-955
37. Pehkonen P, Welter-Stahl L, Diwo J et al (2012) Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages. BMC Genomics 13:50
38. Stulnig TM, Steffensen KR, Gao H et al (2002) Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Mol Pharmacol 62:1299-1305
39. Kulyte A, Pettersson AT, Antonson P et al (2011) CIDEA interacts with liver X receptors in white fat cells. FEBS Lett 585:744-748
40. Sun D, Zhang J, Xie J, Wei W, Chen M, Zhao X (2012) MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7. FEBS Lett 586:1472-1479
41. George S, Rochford JJ, Wolfrum C et al (2004) A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304:1325-1328
42. Lin WH, Chiu KC, Chang HM, Lee KC, Tai TY, Chuang LM (2001) Molecular scanning of the human sorbin and SH3-domain-containing-1 (SORBS1) gene: positive association of the T228A polymorphism with obesity and type 2 diabetes. Hum Mol Genet 10:1753-1760
43. Kim CA, Delepine M, Boutet E et al (2008) Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab 93:1129-1134
44. Zhou QL, Park JG, Jiang ZY et al (2004) Analysis of insulin signalling by RNAi-based gene silencing. Biochem Soc Trans 32:817-821
45. Tan SX, Ng Y, Meoli CC et al (2012) Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes. J Biol Chem 287:6128-6138
46. Katz A, Udata C, Ott E et al (2009) Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. J Clin Pharmacol 49:643-649
47. Stenson BM, Ryden M, Venteclef N et al (2011) Liver X receptor (LXR) regulates human adipocyte lipolysis. J Biol Chem 286:370-379
48. Arner P (2005) Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19:471-482
49. Kase ET, Wensaas AJ, Aas V et al (2005) Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes 54:1108-1115
50. Kase ET, Thoresen GH, Westerlund S, Hojlund K, Rustan AC, Gaster M (2007) Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals. Diabetologia 50:2171-2180